Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 10.52% is 39% above its 5-year average of 7.58%, near the high end of its 5-year range (-27.04%–15.37%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.00% below its 12-month average of 12.38%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
10.52%
OPERATING MARGIN AVG TTM
12.38%
OPERATING MARGIN AVG 3Y
10.65%
OPERATING MARGIN AVG 5Y
7.58%
OPERATING MARGIN AVG 10Y
5.04%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-15.00%
CURRENT VS 3Y AVG
-1.20%
CURRENT VS 5Y AVG
+38.83%
CURRENT VS 10Y AVG
+108.74%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.73%
median of 85 covered companies
CURRENT VS SECTOR MEDIAN
-33.11%
vs the sector median at left
Market Cap
$12.38B
Operating Margin
-19.76%
TTM Avg
-59.77%
3Y Avg
-59.80%
5Y Avg
-72.77%
Market Cap
$13.41B
Operating Margin
-2.39%
TTM Avg
-1.31%
3Y Avg
-6.02%
5Y Avg
0.15%
Market Cap
$11.86B
Operating Margin
18.00%
TTM Avg
16.91%
3Y Avg
21.06%
5Y Avg
16.78%
Market Cap
$13.84B
Operating Margin
11.77%
TTM Avg
17.41%
3Y Avg
16.25%
5Y Avg
15.86%
Market Cap
$13.89B
Operating Margin
39.88%
TTM Avg
32.73%
3Y Avg
24.94%
5Y Avg
21.46%
Market Cap
$11.38B
Operating Margin
13.33%
TTM Avg
15.23%
3Y Avg
16.08%
5Y Avg
17.45%
Market Cap
$11.35B
Operating Margin
20.73%
TTM Avg
14.55%
3Y Avg
18.31%
5Y Avg
20.93%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Penumbra, Inc. (PEN) | $12.64B | 10.52% | 12.38% | 10.65% | 7.58% |
| Tempus AI, Inc. (TEM)vs › | $12.38B | -19.76% | -59.77% | -59.80% | -72.77% |
| Baxter International Inc. (BAX)vs › | $13.41B | -2.39% | -1.31% | -6.02% | 0.15% |
| Encompass Health Corporation (EHC)vs › | $11.86B | 18.00% | 16.91% | 21.06% | 16.78% |
| DaVita Inc. (DVA)vs › | $11.48B | 15.06% | 15.52% | 13.94% | 14.32% |
| The Cooper Companies, Inc. (COO)vs › | $13.84B | 11.77% | 17.41% | 16.25% | 15.86% |
| Exelixis, Inc. (EXEL)vs › | $13.89B | 39.88% | 32.73% | 24.94% | 21.46% |
| Align Technology, Inc. (ALGN)vs › | $11.38B | 13.33% | 15.23% | 16.08% | 17.45% |
| Bio-Techne Corporation (TECH)vs › | $11.35B | 20.73% | 14.55% | 18.31% | 20.93% |
| Globus Medical, Inc. (GMED)vs › | $11.13B | 20.75% | 11.46% | 13.43% | 14.29% |
Gross Margin
67.8%
Operating Margin
10.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 10.52% |
| 2026-03-31 | 10.20% |
| 2025-12-31 | 15.37% |
| 2025-09-30 | 13.77% |
| 2025-06-30 | 12.03% |
| 2025-03-31 | 12.45% |
| 2024-12-31 | 13.56% |
| 2024-09-30 | 11.75% |
| 2024-06-30 | -27.04% |
| 2024-03-31 | 4.34% |
| 2023-12-31 | 12.30% |
| 2023-09-30 | 4.66% |
| 2023-06-30 | 6.84% |
| 2023-03-31 | 3.32% |
| 2022-12-31 | 2.18% |
| 2022-09-30 | 2.54% |
| 2022-06-30 | -0.07% |
| 2022-03-31 | -1.98% |
| 2021-12-31 | -19.63% |
| 2021-09-30 | 4.62% |
| 2021-06-30 | 5.60% |
| 2021-03-31 | 7.96% |
| 2020-12-31 | -1.05% |
| 2020-09-30 | -13.34% |
| 2020-06-30 | -16.79% |
| 2020-03-31 | 0.44% |
| 2019-12-31 | 7.28% |
| 2019-09-30 | 9.30% |
| 2019-06-30 | 9.54% |
| 2019-03-31 | 8.68% |
| 2018-12-31 | 5.52% |
| 2018-09-30 | -18.65% |
| 2018-06-30 | 8.47% |
| 2018-03-31 | 3.94% |
| 2017-12-31 | 4.01% |
| 2017-09-30 | 0.81% |
| 2017-06-30 | -1.65% |
| 2017-03-31 | -2.79% |
| 2016-12-31 | -1.58% |
| 2016-09-30 | -2.03% |
| 2016-06-30 | -1.03% |
| 2016-03-31 | 3.17% |
| 2015-12-31 | 3.34% |
| 2015-09-30 | 4.33% |
| 2015-06-30 | -9.01% |
| 2015-03-31 | 10.24% |
| 2014-12-31 | 0.91% |
| 2014-09-30 | 0.96% |
| 2014-06-30 | 1.70% |
| 2014-03-31 | 7.04% |
